Angitia Biopharmaceuticals
Drug DiscoveryWebsite
Developer of a global clinical-stage biotechnology company intended for the discovery and development of breakthrough therapies. The company focuses on the research and development of drugs for bone, ...
Valuation
$0
Share Price
N/A
Total Raised
$290M
Last Round
Later Stage VC (Series D)
Feb 2026
Latest Funding Round
Later Stage VC (Series D)
Feb 5, 2026
$130M
raised
Investors
+16 other investors